Cargando…
Minimal Change Disease and Primary Sjogren Syndrome Concurrence: Case-Based review
Primary Sjogren’s syndrome is a chronic autoimmune disease with glandular and extraglandular features. Renal involvement is less frequent when compared with other systemic manifestations. Glomerulonephritis is a relatively rare manifestation of primary Sjogren’s syndrome. Among all types of glomerul...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mesut Onat
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089134/ https://www.ncbi.nlm.nih.gov/pubmed/36052636 http://dx.doi.org/10.5152/eurjrheum.2022.20246 |
_version_ | 1785022705282580480 |
---|---|
author | Şule Yaşar Bilge, Nazife Özkurt, Sultan Fuat Açıkalın, Mustafa Kaşifoğlu, Timuçin |
author_facet | Şule Yaşar Bilge, Nazife Özkurt, Sultan Fuat Açıkalın, Mustafa Kaşifoğlu, Timuçin |
author_sort | Şule Yaşar Bilge, Nazife |
collection | PubMed |
description | Primary Sjogren’s syndrome is a chronic autoimmune disease with glandular and extraglandular features. Renal involvement is less frequent when compared with other systemic manifestations. Glomerulonephritis is a relatively rare manifestation of primary Sjogren’s syndrome. Among all types of glomerular manifestations, minimal change disease is rarely identified, and there are only a few cases in the literature. Herein, we present a 53-year-old male patient who was diagnosed with primary Sjogren’s syndrome and minimal change disease while searching for the etiopathogenesis of nephrotic syndrome. The patient had edema, dyspnea, hypertension, and 12 g/day proteinuria at admission. Serum albumin level was 1.82 g/dL, and renal function tests were within normal ranges. Renal biopsy findings were consistent with minimal change disease. At the same time, he was diagnosed with primary Sjogren’s syndrome based on dry eyes demonstrated with Schirmer’s test, positive antinuclear antibody, anti-SS-A, and anti-SS-B antibodies. Hydroxychloroquine with methylprednisolone 1 mg/kg (64 mg/day) was started, and methylprednisolone was slowly tapered. His proteinuria regressed to 79.2 mg/day, creatinine level was 0.83 mg/dL, and serum albumin level increased to 3.88 g/dL on the second week of the glucocorticoid treatment. In this case-based review, we present our case with 5 other reports of minimal change disease associated with primary Sjogren’s syndrome. Our aim was to increase the awareness of this rare concurrence both among rheumatologists and nephrologists in light of the literature review. |
format | Online Article Text |
id | pubmed-10089134 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Mesut Onat |
record_format | MEDLINE/PubMed |
spelling | pubmed-100891342023-04-12 Minimal Change Disease and Primary Sjogren Syndrome Concurrence: Case-Based review Şule Yaşar Bilge, Nazife Özkurt, Sultan Fuat Açıkalın, Mustafa Kaşifoğlu, Timuçin Eur J Rheumatol Case based Review Primary Sjogren’s syndrome is a chronic autoimmune disease with glandular and extraglandular features. Renal involvement is less frequent when compared with other systemic manifestations. Glomerulonephritis is a relatively rare manifestation of primary Sjogren’s syndrome. Among all types of glomerular manifestations, minimal change disease is rarely identified, and there are only a few cases in the literature. Herein, we present a 53-year-old male patient who was diagnosed with primary Sjogren’s syndrome and minimal change disease while searching for the etiopathogenesis of nephrotic syndrome. The patient had edema, dyspnea, hypertension, and 12 g/day proteinuria at admission. Serum albumin level was 1.82 g/dL, and renal function tests were within normal ranges. Renal biopsy findings were consistent with minimal change disease. At the same time, he was diagnosed with primary Sjogren’s syndrome based on dry eyes demonstrated with Schirmer’s test, positive antinuclear antibody, anti-SS-A, and anti-SS-B antibodies. Hydroxychloroquine with methylprednisolone 1 mg/kg (64 mg/day) was started, and methylprednisolone was slowly tapered. His proteinuria regressed to 79.2 mg/day, creatinine level was 0.83 mg/dL, and serum albumin level increased to 3.88 g/dL on the second week of the glucocorticoid treatment. In this case-based review, we present our case with 5 other reports of minimal change disease associated with primary Sjogren’s syndrome. Our aim was to increase the awareness of this rare concurrence both among rheumatologists and nephrologists in light of the literature review. Mesut Onat 2022-10-01 /pmc/articles/PMC10089134/ /pubmed/36052636 http://dx.doi.org/10.5152/eurjrheum.2022.20246 Text en 2022 authors https://creativecommons.org/licenses/by-nc/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | Case based Review Şule Yaşar Bilge, Nazife Özkurt, Sultan Fuat Açıkalın, Mustafa Kaşifoğlu, Timuçin Minimal Change Disease and Primary Sjogren Syndrome Concurrence: Case-Based review |
title | Minimal Change Disease and Primary Sjogren Syndrome Concurrence: Case-Based review |
title_full | Minimal Change Disease and Primary Sjogren Syndrome Concurrence: Case-Based review |
title_fullStr | Minimal Change Disease and Primary Sjogren Syndrome Concurrence: Case-Based review |
title_full_unstemmed | Minimal Change Disease and Primary Sjogren Syndrome Concurrence: Case-Based review |
title_short | Minimal Change Disease and Primary Sjogren Syndrome Concurrence: Case-Based review |
title_sort | minimal change disease and primary sjogren syndrome concurrence: case-based review |
topic | Case based Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089134/ https://www.ncbi.nlm.nih.gov/pubmed/36052636 http://dx.doi.org/10.5152/eurjrheum.2022.20246 |
work_keys_str_mv | AT suleyasarbilgenazife minimalchangediseaseandprimarysjogrensyndromeconcurrencecasebasedreview AT ozkurtsultan minimalchangediseaseandprimarysjogrensyndromeconcurrencecasebasedreview AT fuatacıkalınmustafa minimalchangediseaseandprimarysjogrensyndromeconcurrencecasebasedreview AT kasifoglutimucin minimalchangediseaseandprimarysjogrensyndromeconcurrencecasebasedreview |